o(6)-benzylguanine has been researched along with Kahler Disease in 1 studies
O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity
Excerpt | Relevance | Reference |
---|---|---|
"Carmustine (BCNU) is known to have modest activity in multiple myeloma; however, resistance to BCNU manifests by the activity of O6-methylguanine methyltransferase (MGMT)." | 9.12 | O6-benzylguanine and BCNU in multiple myeloma: a phase II trial. ( Bahlis, N; Batts, ED; Fu, P; Gerson, SL; Kane, D; Liu, L; Maisel, C; O'Brien, T; Remick, S, 2007) |
"Carmustine (BCNU) is known to have modest activity in multiple myeloma; however, resistance to BCNU manifests by the activity of O6-methylguanine methyltransferase (MGMT)." | 5.12 | O6-benzylguanine and BCNU in multiple myeloma: a phase II trial. ( Bahlis, N; Batts, ED; Fu, P; Gerson, SL; Kane, D; Liu, L; Maisel, C; O'Brien, T; Remick, S, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batts, ED | 1 |
Maisel, C | 1 |
Kane, D | 1 |
Liu, L | 1 |
Fu, P | 1 |
O'Brien, T | 1 |
Remick, S | 1 |
Bahlis, N | 1 |
Gerson, SL | 1 |
1 trial available for o(6)-benzylguanine and Kahler Disease
Article | Year |
---|---|
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; DNA; Drug Administration Sc | 2007 |